APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaccines For Children

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Vaccines For Children Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025190 pages

Choose your research edition.

Industry ResearchVaccines For Children Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccines For Children Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Vaccines For Children Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccines For Children Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccines For Children Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Vaccines For Children market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Vaccines For Children is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vaccines For Children is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vaccines For Children is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Vaccines For Children is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vaccines For Children include GSK, CSL, Hissen, J&J(Crucell), Jintan, MedImmune LLC, Tiantan, Hualan and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Vaccines For Children market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vaccines For Children and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vaccines For Children sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vaccines For Children market size, projected growth trends, production technologies, key applications, and end-use industries.

Vaccines For Children Segment by Company

GSK

CSL

Hissen

J&J(Crucell)

Jintan

MedImmune LLC

Tiantan

Hualan

Pfizer

Kangtai

Merck

Sanofi

China National Biotec

Vaccines For Children Segment by Type

Recombinant Vaccines

Polysaccharide Vaccines

Viral Vaccines

Others

Vaccines For Children Segment by Application

Hospital

Clinic

Vaccines For Children Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccines For Children market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccines For Children and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccines For Children.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vaccines For Children market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vaccines For Children manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Vaccines For Children in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Vaccines For Children in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Vaccines For Children Industry Trends Table 2. Vaccines For Children Industry Drivers Table 3. Vaccines For Children Industry Opportunities and Challenges Table 4. Vaccines For Children Industry Restraints Table 5. Global Vaccines For Children Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Vaccines For Children Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Vaccines For Children Sales by Manufacturers (K Doses) & (2021-2026) Table 8. Global Vaccines For Children Sales Market Share by Manufacturers Table 9. Global Vaccines For Children Average Sales Price (US$/Dose) of Manufacturers (2021-2026) Table 10. Global Vaccines For Children Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Vaccines For Children Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Vaccines For Children Manufacturers, Product Type & Application Table 13. Global Vaccines For Children Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Vaccines For Children by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Recombinant Vaccines Table 17. Major Manufacturers of Polysaccharide Vaccines Table 18. Major Manufacturers of Viral Vaccines Table 19. Major Manufacturers of Others Table 20. Global Vaccines For Children Sales by Type 2021 VS 2025 VS 2032 (K Doses) Table 21. Global Vaccines For Children Sales by Type (2021-2026) & (K Doses) Table 22. Global Vaccines For Children Sales by Type (2027-2032) & (K Doses) Table 23. Global Vaccines For Children Sales Market Share by Type (2021-2026) Table 24. Global Vaccines For Children Sales Market Share by Type (2027-2032) Table 25. Global Vaccines For Children Revenue by Type 2021 VS 2025 VS 2032 (K Doses) Table 26. Global Vaccines For Children Revenue by Type (2021-2026) & (K Doses) Table 27. Global Vaccines For Children Revenue by Type (2027-2032) & (K Doses) Table 28. Global Vaccines For Children Revenue Market Share by Type (2021-2026) Table 29. Global Vaccines For Children Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Clinic Table 32. Global Vaccines For Children Sales by Application 2021 VS 2025 VS 2032 (K Doses) Table 33. Global Vaccines For Children Sales by Application (2021-2026) & (K Doses) Table 34. Global Vaccines For Children Sales by Application (2027-2032) & (K Doses) Table 35. Global Vaccines For Children Sales Market Share by Application (2021-2026) Table 36. Global Vaccines For Children Sales Market Share by Application (2027-2032) Table 37. Global Vaccines For Children Revenue by Application 2021 VS 2025 VS 2032 (K Doses) Table 38. Global Vaccines For Children Revenue by Application (2021-2026) & (K Doses) Table 39. Global Vaccines For Children Revenue by Application (2027-2032) & (K Doses) Table 40. Global Vaccines For Children Revenue Market Share by Application (2021-2026) Table 41. Global Vaccines For Children Revenue Market Share by Application (2027-2032) Table 42. Global Vaccines For Children Sales by Region: 2021 VS 2025 VS 2032 (K Doses) Table 43. Global Vaccines For Children Sales by Region (2021-2026) & (K Doses) Table 44. Global Vaccines For Children Sales Market Share by Region (2021-2026) Table 45. Global Vaccines For Children Sales Forecasted by Region (2027-2032) & (K Doses) Table 46. Global Vaccines For Children Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Vaccines For Children Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 48. North America Vaccines For Children Sales by Country (2021-2026) & (K Doses) Table 49. North America Vaccines For Children Sales by Country (2027-2032) & (K Doses) Table 50. Europe Vaccines For Children Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 51. Europe Vaccines For Children Sales by Country (2021-2026) & (K Doses) Table 52. Europe Vaccines For Children Sales by Country (2027-2032) & (K Doses) Table 53. Asia Pacific Vaccines For Children Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 54. Asia Pacific Vaccines For Children Sales by Country (2021-2026) & (K Doses) Table 55. Asia Pacific Vaccines For Children Sales by Country (2027-2032) & (K Doses) Table 56. South America, Middle East and Africa Vaccines For Children Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 57. South America, Middle East and Africa Vaccines For Children Sales by Country (2021-2026) & (K Doses) Table 58. South America, Middle East and Africa Vaccines For Children Sales by Country (2027-2032) & (K Doses) Table 59. Global Vaccines For Children Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Vaccines For Children Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Vaccines For Children Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Vaccines For Children Revenue Market Share by Region (2021-2026) Table 63. Global Vaccines For Children Revenue Market Share by Region (2027-2032) Table 64. GSK Company Information Table 65. GSK Business Overview Table 66. GSK Vaccines For Children Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. GSK Vaccines For Children Product Portfolio Table 68. GSK Recent Development Table 69. CSL Company Information Table 70. CSL Business Overview Table 71. CSL Vaccines For Children Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. CSL Vaccines For Children Product Portfolio Table 73. CSL Recent Development Table 74. Hissen Company Information Table 75. Hissen Business Overview Table 76. Hissen Vaccines For Children Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Hissen Vaccines For Children Product Portfolio Table 78. Hissen Recent Development Table 79. J&J(Crucell) Company Information Table 80. J&J(Crucell) Business Overview Table 81. J&J(Crucell) Vaccines For Children Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. J&J(Crucell) Vaccines For Children Product Portfolio Table 83. J&J(Crucell) Recent Development Table 84. Jintan Company Information Table 85. Jintan Business Overview Table 86. Jintan Vaccines For Children Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Jintan Vaccines For Children Product Portfolio Table 88. Jintan Recent Development Table 89. MedImmune LLC Company Information Table 90. MedImmune LLC Business Overview Table 91. MedImmune LLC Vaccines For Children Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. MedImmune LLC Vaccines For Children Product Portfolio Table 93. MedImmune LLC Recent Development Table 94. Tiantan Company Information Table 95. Tiantan Business Overview Table 96. Tiantan Vaccines For Children Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Tiantan Vaccines For Children Product Portfolio Table 98. Tiantan Recent Development Table 99. Hualan Company Information Table 100. Hualan Business Overview Table 101. Hualan Vaccines For Children Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Hualan Vaccines For Children Product Portfolio Table 103. Hualan Recent Development Table 104. Pfizer Company Information Table 105. Pfizer Business Overview Table 106. Pfizer Vaccines For Children Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Pfizer Vaccines For Children Product Portfolio Table 108. Pfizer Recent Development Table 109. Kangtai Company Information Table 110. Kangtai Business Overview Table 111. Kangtai Vaccines For Children Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Kangtai Vaccines For Children Product Portfolio Table 113. Kangtai Recent Development Table 114. Merck Company Information Table 115. Merck Business Overview Table 116. Merck Vaccines For Children Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Merck Vaccines For Children Product Portfolio Table 118. Merck Recent Development Table 119. Sanofi Company Information Table 120. Sanofi Business Overview Table 121. Sanofi Vaccines For Children Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Sanofi Vaccines For Children Product Portfolio Table 123. Sanofi Recent Development Table 124. China National Biotec Company Information Table 125. China National Biotec Business Overview Table 126. China National Biotec Vaccines For Children Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. China National Biotec Vaccines For Children Product Portfolio Table 128. China National Biotec Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Vaccines For Children Distributors List Table 132. Vaccines For Children Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Vaccines For Children Product Image Figure 2. Global Vaccines For Children Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vaccines For Children Market Size (2021-2032) & (US$ Million) Figure 4. Global Vaccines For Children Sales (2021-2032) & (K Doses) Figure 5. Global Vaccines For Children Average Price (US$/Dose) & (2021-2032) Figure 6. Global Top 5 and 10 Vaccines For Children Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Recombinant Vaccines Image Figure 9. Polysaccharide Vaccines Image Figure 10. Viral Vaccines Image Figure 11. Others Image Figure 12. Global Vaccines For Children Sales by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 13. Global Vaccines For Children Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Vaccines For Children Sales Market Share by Type (2021-2032) Figure 15. Global Vaccines For Children Revenue by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 16. Global Vaccines For Children Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Vaccines For Children Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Global Vaccines For Children Sales by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 21. Global Vaccines For Children Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Vaccines For Children Sales Market Share by Application (2021-2032) Figure 23. Global Vaccines For Children Revenue by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 24. Global Vaccines For Children Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Vaccines For Children Revenue Market Share by Application (2021-2032) Figure 26. North America Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 27. North America Vaccines For Children Sales Market Share by Country (2021-2032) Figure 28. U.S. Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 29. Canada Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 30. Mexico Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 31. Europe Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 32. Europe Vaccines For Children Sales Market Share by Country (2021-2032) Figure 33. Germany Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 34. France Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 35. U.K. Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 36. Italy Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 37. Netherlands Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 38. Asia Pacific Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 39. Asia Pacific Vaccines For Children Sales Market Share by Country (2021-2032) Figure 40. China Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 41. Japan Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 42. South Korea Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 43. Southeast Asia Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 44. India Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 45. Australia Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 46. South America, Middle East and Africa Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 47. South America, Middle East and Africa Vaccines For Children Sales Market Share by Country (2021-2032) Figure 48. Brazil Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 49. South Africa Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 50. Saudi Arabia Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 51. Turkey Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 52. Argentina Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 53. UAE Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 54. Egypt Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 55. Chile Vaccines For Children Sales and Growth Rate (2021-2032) & (K Doses) Figure 56. Global Vaccines For Children Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Vaccines For Children Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Vaccines For Children Revenue (2021-2032) & (US$ Million) Figure 59. North America Vaccines For Children Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Vaccines For Children Revenue (2021-2032) & (US$ Million) Figure 61. Europe Vaccines For Children Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Vaccines For Children Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Vaccines For Children Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Vaccines For Children Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Vaccines For Children Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Vaccines For Children Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Vaccines For Children Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Vaccines
  • Polysaccharide Vaccines
  • Viral Vaccines
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • GSK
  • CSL
  • Hissen
  • J&J(Crucell)
  • Jintan
  • MedImmune LLC
  • Tiantan
  • Hualan
  • Pfizer
  • Kangtai
  • Merck
  • Sanofi
  • China National Biotec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Vaccines For Children Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Vaccines For Children Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Vaccines For Children Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Vaccines For Children Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Vaccines For Children Market Dynamics
  1. 2.1 Vaccines For Children Industry Trends
  2. 2.2 Vaccines For Children Industry Drivers
  3. 2.3 Vaccines For Children Industry Opportunities and Challenges
  4. 2.4 Vaccines For Children Industry Restraints
3 Vaccines For Children Market by Manufacturers
  1. 3.1 Global Vaccines For Children Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Vaccines For Children Sales by Manufacturers (2021-2026)
  3. 3.3 Global Vaccines For Children Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Vaccines For Children Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vaccines For Children Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Vaccines For Children Manufacturers, Product Type & Application
  7. 3.7 Global Vaccines For Children Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vaccines For Children Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vaccines For Children Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vaccines For Children Tier 1, Tier 2, and Tier 3
4 Vaccines For Children Market by Type
  1. 4.1 Vaccines For Children Type Introduction
  2. 4.1.1 Recombinant Vaccines
  3. 4.1.2 Polysaccharide Vaccines
  4. 4.1.3 Viral Vaccines
  5. 4.1.4 Others
  6. 4.2 Global Vaccines For Children Sales by Type
  7. 4.2.1 Global Vaccines For Children Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Vaccines For Children Sales by Type (2021-2032)
  9. 4.2.3 Global Vaccines For Children Sales Market Share by Type (2021-2032)
  10. 4.3 Global Vaccines For Children Revenue by Type
  11. 4.3.1 Global Vaccines For Children Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Vaccines For Children Revenue by Type (2021-2032)
  13. 4.3.3 Global Vaccines For Children Revenue Market Share by Type (2021-2032)
5 Vaccines For Children Market by Application
  1. 5.1 Vaccines For Children Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Vaccines For Children Sales by Application
  5. 5.2.1 Global Vaccines For Children Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Vaccines For Children Sales by Application (2021-2032)
  7. 5.2.3 Global Vaccines For Children Sales Market Share by Application (2021-2032)
  8. 5.3 Global Vaccines For Children Revenue by Application
  9. 5.3.1 Global Vaccines For Children Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Vaccines For Children Revenue by Application (2021-2032)
  11. 5.3.3 Global Vaccines For Children Revenue Market Share by Application (2021-2032)
6 Global Vaccines For Children Sales by Region
  1. 6.1 Global Vaccines For Children Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vaccines For Children Sales by Region (2021-2032)
  3. 6.2.1 Global Vaccines For Children Sales by Region (2021-2026)
  4. 6.2.2 Global Vaccines For Children Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Vaccines For Children Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Vaccines For Children Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Vaccines For Children Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Vaccines For Children Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Vaccines For Children Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Vaccines For Children Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Vaccines For Children Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Vaccines For Children Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Vaccines For Children Revenue by Region
  1. 7.1 Global Vaccines For Children Revenue by Region
  2. 7.1.1 Global Vaccines For Children Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Vaccines For Children Revenue by Region (2021-2026)
  4. 7.1.3 Global Vaccines For Children Revenue by Region (2027-2032)
  5. 7.1.4 Global Vaccines For Children Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Vaccines For Children Revenue (2021-2032)
  8. 7.2.2 North America Vaccines For Children Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Vaccines For Children Revenue (2021-2032)
  11. 7.3.2 Europe Vaccines For Children Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Vaccines For Children Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Vaccines For Children Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Vaccines For Children Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Vaccines For Children Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Vaccines For Children Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GSK Vaccines For Children Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 CSL
  8. 8.2.1 CSL Company Information
  9. 8.2.2 CSL Business Overview
  10. 8.2.3 CSL Vaccines For Children Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CSL Vaccines For Children Product Portfolio
  12. 8.2.5 CSL Recent Developments
  13. 8.3 Hissen
  14. 8.3.1 Hissen Company Information
  15. 8.3.2 Hissen Business Overview
  16. 8.3.3 Hissen Vaccines For Children Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hissen Vaccines For Children Product Portfolio
  18. 8.3.5 Hissen Recent Developments
  19. 8.4 J&J(Crucell)
  20. 8.4.1 J&J(Crucell) Company Information
  21. 8.4.2 J&J(Crucell) Business Overview
  22. 8.4.3 J&J(Crucell) Vaccines For Children Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 J&J(Crucell) Vaccines For Children Product Portfolio
  24. 8.4.5 J&J(Crucell) Recent Developments
  25. 8.5 Jintan
  26. 8.5.1 Jintan Company Information
  27. 8.5.2 Jintan Business Overview
  28. 8.5.3 Jintan Vaccines For Children Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Jintan Vaccines For Children Product Portfolio
  30. 8.5.5 Jintan Recent Developments
  31. 8.6 MedImmune LLC
  32. 8.6.1 MedImmune LLC Company Information
  33. 8.6.2 MedImmune LLC Business Overview
  34. 8.6.3 MedImmune LLC Vaccines For Children Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 MedImmune LLC Vaccines For Children Product Portfolio
  36. 8.6.5 MedImmune LLC Recent Developments
  37. 8.7 Tiantan
  38. 8.7.1 Tiantan Company Information
  39. 8.7.2 Tiantan Business Overview
  40. 8.7.3 Tiantan Vaccines For Children Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Tiantan Vaccines For Children Product Portfolio
  42. 8.7.5 Tiantan Recent Developments
  43. 8.8 Hualan
  44. 8.8.1 Hualan Company Information
  45. 8.8.2 Hualan Business Overview
  46. 8.8.3 Hualan Vaccines For Children Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hualan Vaccines For Children Product Portfolio
  48. 8.8.5 Hualan Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer Vaccines For Children Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Vaccines For Children Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 Kangtai
  56. 8.10.1 Kangtai Company Information
  57. 8.10.2 Kangtai Business Overview
  58. 8.10.3 Kangtai Vaccines For Children Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Kangtai Vaccines For Children Product Portfolio
  60. 8.10.5 Kangtai Recent Developments
  61. 8.11 Merck
  62. 8.11.1 Merck Company Information
  63. 8.11.2 Merck Business Overview
  64. 8.11.3 Merck Vaccines For Children Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Merck Vaccines For Children Product Portfolio
  66. 8.11.5 Merck Recent Developments
  67. 8.12 Sanofi
  68. 8.12.1 Sanofi Company Information
  69. 8.12.2 Sanofi Business Overview
  70. 8.12.3 Sanofi Vaccines For Children Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sanofi Vaccines For Children Product Portfolio
  72. 8.12.5 Sanofi Recent Developments
  73. 8.13 China National Biotec
  74. 8.13.1 China National Biotec Company Information
  75. 8.13.2 China National Biotec Business Overview
  76. 8.13.3 China National Biotec Vaccines For Children Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 China National Biotec Vaccines For Children Product Portfolio
  78. 8.13.5 China National Biotec Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vaccines For Children Value Chain Analysis
  2. 9.1.1 Vaccines For Children Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vaccines For Children Production Mode & Process
  6. 9.2 Vaccines For Children Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vaccines For Children Distributors
  9. 9.2.3 Vaccines For Children Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst